The increased risk of ovarian cancer was evident only for the relatives of known BRCA1 mutation carriers, and the increased risk of prostate cancer was evident only for the relatives of known BRCA2 mutation carriers. This evidence concerns the gene BRCA1 and ovarian cancer.